Show simple item record

dc.contributor.authorTyminska, Agata
dc.contributor.authorKaplon-Cieslicka, Agnieszka
dc.contributor.authorOzieranski, Krzysztof
dc.contributor.authorPeller, Michal
dc.contributor.authorBalsam, Pawel
dc.contributor.authorMarchel, Michal
dc.contributor.authorCrespo-Leiro, María Generosa
dc.contributor.authorMaggioni, Aldo P.
dc.contributor.authorJankowska, Ewa A.
dc.contributor.authorDrozdz, Jaroslaw
dc.contributor.authorFilipiak, Krzysztof J.
dc.contributor.authorOpolski, Grzegorz
dc.date.accessioned2019-02-26T09:49:16Z
dc.date.available2019-02-26T09:49:16Z
dc.date.issued2017
dc.identifier.citationTyminska A, Kaplon-Cieslicka A, Ozieranski K, et al. Anemia at hospital admission and its relation to outcomes in patients with heart failure (from the polish cohort of 2 European Society of Cardiology Heart Failure Registries). Am J Cardiol. 2017; 119(12): 2021-2029es_ES
dc.identifier.issn0002-9149
dc.identifier.urihttp://hdl.handle.net/2183/21964
dc.description.abstract[Abstract] Anemia is a commonly observed co-morbidity in heart failure (HF). The aim of the study was to assess prevalence, risk factors for, and effect of anemia on short- and long-term outcomes in HF. The study included 1,394 Caucasian patients hospitalized for HF, with known hemoglobin concentration on hospital admission, participating in 2 HF registries of the European Society of Cardiology (Pilot and Long-Term). Anemia was defined as hemoglobin concentration of <13 g/dl for men and <12 g/dl for women. Primary end points were (1) all-cause death at 1 year and (2) a composite of all-cause death and rehospitalization for HF at 1 year. Secondary end points included inter alia death during index hospitalization. In addition, we investigated the effect of changes in hemoglobin concentration during hospitalization on prognosis. Anemia occurred in 33% of patients. Predictors of anemia included older age, diabetes, greater New York Heart Association class at hospital admission and kidney disease. During 1-year follow-up, 21% of anemic and 13% of nonanemic patients died (p <0.0001). Combined primary end point occurred in 45% of anemic and in 33% of nonanemic patients (p <0.0001). Anemia was strongly predictive of all the prespecified clinical end points in univariate analyses but not in multivariate analyses. Changes in hemoglobin concentration during hospitalization had no effect on 1-year outcomes. In conclusion, anemia was present in 1/3 of patients with HF. Mild-to-moderate anemia seems more a marker of older age, worse clinical condition, and a higher co-morbidity burden, rather than an independent risk factor in HF.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.urihttps://doi.org/10.1016/j.amjcard.2017.03.035es_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Españaes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectAnemiaes_ES
dc.subjectCardiologyes_ES
dc.subjectComorbidityes_ES
dc.subjectHeart failurees_ES
dc.subjectHemoglobinses_ES
dc.subjectPatient admissiones_ES
dc.subjectRegistrieses_ES
dc.subjectRisk assessmentes_ES
dc.subjectSurvival ratees_ES
dc.titleAnemia at hospital admission and its relation to outcomes in patients with heart failure (from the polish cohort of 2 European Society of Cardiology Heart Failure Registries)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleThe American Journal of Cardiologyes_ES
UDC.volume119es_ES
UDC.issue12es_ES
UDC.startPage2021es_ES
UDC.endPage2029es_ES


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record